<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37646849</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-8491</ISSN><JournalIssue CitedMedium="Internet"><Volume>274</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European archives of psychiatry and clinical neuroscience</Title><ISOAbbreviation>Eur Arch Psychiatry Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Levels of brain-derived neurotrophic factor (BDNF) among patients with COVID-19: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1137</StartPage><EndPage>1152</EndPage><MedlinePgn>1137-1152</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00406-023-01681-z</ELocationID><Abstract><AbstractText>Many individuals have been suffering from consistent neurological and neuropsychiatric manifestations even after the remission of coronavirus disease (COVID-19). Brain-derived neurotrophic factor (BDNF) is a protein involved in the regulation of several processes, including neuroplasticity, neurogenesis, and neuronal differentiation, and has been linked to a range of neurological and psychiatric disorders. In this study, we aimed to synthesize the available evidence on the profile of BDNF in COVID-19. A comprehensive search was done in the Web of Science core collection, Scopus, and MEDLINE (PubMed), and Embase to identify relevant studies reporting the level of BDNF in patients with COVID-19 or those suffering from long COVID. We used the NEWCASTLE-OTTAWA tool for quality assessment. We pooled the effect sizes of individual studies using the random effect model for our meta-analysis. Fifteen articles were included in the systematic review. The sample sizes ranged from 16 to 183 participants. Six studies compared the level of BDNF in COVID-19 patients with healthy controls. The pooled estimate of the standardized mean difference in BDNF level between patients with COVID-19 and healthy individuals was -&#x2009;0.84 (95% CI -&#x2009;1.49 to -&#x2009;0.18, p&#x2009;=&#x2009;0.01, I2&#x2009;=&#x2009;81%) indicating a significantly lower BDNF level in patients with COVID-19. Seven studies assessed BDNF in different severity statuses of patients with COVID-19. The pooled estimate of the standardized mean difference in BDNF level was -&#x2009;0.53 (95% CI -&#x2009;0.85 to -&#x2009;0.21, p&#x2009;=&#x2009;0.001, I2&#x2009;=&#x2009;46%), indicating a significantly lower BDNF level in patients with more severe COVID-19. Three studies evaluated BDNF levels in COVID-19 patients through different follow-up periods. Only one study assessed the BDNF levels in long COVID patients. Sensitivity analyses did not alter the significance of the association. In this study, we showed a significant dysregulation of BDNF following COVID-19 infection. These findings may support the pathogenesis behind the long-lasting effects of this disease among infected patients. PROSPERO: CRD42023413536.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shafiee</LastName><ForeName>Arman</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1941-4399</Identifier><AffiliationInfo><Affiliation>Student Research Committee, School of Medicine, Alborz University of Medical Science, Karaj, Iran. armanshafieemd@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seighali</LastName><ForeName>Niloofar</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Student Research Committee, School of Medicine, Alborz University of Medical Science, Karaj, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teymouri Athar</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdollahi</LastName><ForeName>Abolfazl King</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Student Research Committee, School of Medicine, Alborz University of Medical Science, Karaj, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafarabady</LastName><ForeName>Kyana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Student Research Committee, School of Medicine, Alborz University of Medical Science, Karaj, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakhtiyari</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Community Medicine and Epidemiology, Alborz University of Medical Sciences, Karaj, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Arch Psychiatry Clin Neurosci</MedlineTA><NlmUniqueID>9103030</NlmUniqueID><ISSNLinking>0940-1334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>7171WSG8A2</RegistryNumber><NameOfSubstance UI="C579455">BDNF protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019208" MajorTopicYN="Y">Brain-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BDNF</Keyword><Keyword MajorTopicYN="N">Brain-derived neurotrophic factor</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>5</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>11</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37646849</ArticleId><ArticleId IdType="doi">10.1007/s00406-023-01681-z</ArticleId><ArticleId IdType="pii">10.1007/s00406-023-01681-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>He F, Deng Y, Li W (2019) Coronavirus disease 2019: What we know?. J Med Virol. 2020 Jul;92(7):719-25.</Citation></Reference><Reference><Citation>Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S et al (2021) Long COVID, a comprehensive systematic scoping review. Infection 49(6):1163&#x2013;1186</Citation><ArticleIdList><ArticleId IdType="pubmed">34319569</ArticleId><ArticleId IdType="pmc">8317481</ArticleId><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiee A, Teymouri Athar MM, Amini MJ, Hajishah H, Siahvoshi S, Jalali M, Jahanbakhshi B, Mozhgani SH (2023) Reactivation of herpesviruses during COVID&#x2010;19: A systematic review and meta&#x2010;analysis. Rev Med Virol 33(3):e2437</Citation></Reference><Reference><Citation>Wang CS, Kavalali ET, Monteggia LM (2022) BDNF signaling in context: from synaptic regulation to psychiatric disorders. Cell 185(1):62&#x2013;76</Citation><ArticleIdList><ArticleId IdType="pubmed">34963057</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2021.12.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo A, Cattane N, Begni V, Pariante CM, Riva MA (2016) The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders. Transl Psychiatry 6(11):e958</Citation><ArticleIdList><ArticleId IdType="pubmed">27874848</ArticleId><ArticleId IdType="pmc">5314126</ArticleId><ArticleId IdType="doi">10.1038/tp.2016.214</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiee A, Rezaian S, Aliyu M, Shayeghpour A, Mokhames Z, Mohammadi H et al (2023) Immunologic profile of severe COVID-19 patients in Alborz Province. Iran 16(1):e134264</Citation></Reference><Reference><Citation>Queiroz MAF, Neves P, Lima SS, Lopes JDC, Torres M, Vallinoto I et al (2022) Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front Cell Infect Microbiol 12:922422</Citation><ArticleIdList><ArticleId IdType="pubmed">35846757</ArticleId><ArticleId IdType="pmc">9279918</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgarzadeh A, Fouladi N, Asghariazar V, Sarabi SF, Khiavi HA, Mahmoudi M et al (2022) Serum brain-derived neurotrophic factor (BDNF) in COVID-19 patients and its association with the COVID-19 manifestations. J Mol Neurosci MN 72(9):1820&#x2013;1830</Citation><ArticleIdList><ArticleId IdType="pubmed">35749045</ArticleId><ArticleId IdType="doi">10.1007/s12031-022-02039-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Demir B, Beyazy&#xfc;z E, Beyazy&#xfc;z M, &#xc7;elikkol A, Albayrak Y (2022) Long-lasting cognitive effects of COVID-19: is there a role of BDNF? Eur Arch Psychiatry Clin Neurosci. https://doi.org/10.1007/s00406-022-01514-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-022-01514-5</ArticleId><ArticleId IdType="pubmed">36355087</ArticleId><ArticleId IdType="pmc">9648433</ArticleId></ArticleIdList></Reference><Reference><Citation>Motaghinejad M, Gholami M (2020) Possible neurological and mental outcomes of COVID-19 infection: a hypothetical role of ACE-2\Mas\BDNF signaling pathway. Int J Prev Med 11:84</Citation><ArticleIdList><ArticleId IdType="pubmed">33042481</ArticleId><ArticleId IdType="pmc">7518341</ArticleId><ArticleId IdType="doi">10.4103/ijpvm.IJPVM_114_20</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135</Citation><ArticleIdList><ArticleId IdType="pubmed">25524443</ArticleId><ArticleId IdType="pmc">4383202</ArticleId><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchini C, Stubbs B, Solmi M, Veronese N (2017) Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale. World J Meta-Anal 5(4):80&#x2013;84</Citation><ArticleIdList><ArticleId IdType="doi">10.13105/wjma.v5.i4.80</ArticleId></ArticleIdList></Reference><Reference><Citation>Azoulay D, Shehadeh M, Chepa S, Shaoul E, Baroum M, Horowitz NA et al (2020) Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration. J Infect 81(3):e79&#x2013;e81</Citation><ArticleIdList><ArticleId IdType="pubmed">32569603</ArticleId><ArticleId IdType="pmc">7305721</ArticleId><ArticleId IdType="doi">10.1016/j.jinf.2020.06.038</ArticleId></ArticleIdList></Reference><Reference><Citation>Biamonte F, Re A, Balzamino BO, Ciasca G, Santucci D, Napodano C et al (2022) Circulating and salivary NGF and BDNF levels in SARS-CoV-2 infection: potential predictor biomarkers of COVID-19 disease-preliminary data. J Pers Med 12(11):12</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12111877</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan YH, Fong SW, Poh CM, Carissimo G, Yeo NK, Amrun SN et al (2021) Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2. EMBO Mol Med 13(6):e14045</Citation><ArticleIdList><ArticleId IdType="pubmed">33961735</ArticleId><ArticleId IdType="pmc">8185544</ArticleId><ArticleId IdType="doi">10.15252/emmm.202114045</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorgojo-Galindo &#xd3;, Mart&#xed;n-Fern&#xe1;ndez M, Pe&#xf1;arrubia-Ponce MJ, &#xc1;lvarez FJ, Ortega-Loubon C, Gonzalo-Benito H et al (2021) Predictive modeling of poor outcome in severe covid-19: a single-center observational study based on clinical, cytokine and laboratory profiles. J Clin Med 10(22):5431</Citation><ArticleIdList><ArticleId IdType="pubmed">34830714</ArticleId><ArticleId IdType="pmc">8622763</ArticleId><ArticleId IdType="doi">10.3390/jcm10225431</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffre J, Rodriguez L, Matthay ZA, Lloyd E, Fields AT, Bainton RJ et al (2022) COVID-19&#x2013;associated Lung microvascular endotheliopathy a &#x201c;From the Bench&#x201d; perspective. Am J Respir Crit Care Med 206(8):961&#x2013;972</Citation><ArticleIdList><ArticleId IdType="pubmed">35649173</ArticleId><ArticleId IdType="pmc">9801996</ArticleId><ArticleId IdType="doi">10.1164/rccm.202107-1774OC</ArticleId></ArticleIdList></Reference><Reference><Citation>Joob B, Wiwanitkit V (2022) Serum BDNF in COVID-19 patients: a summative analysis. J Datta Meghe Inst Med Sci Univ 17(4):1028</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jdmimsu.jdmimsu_121_21</ArticleId></ArticleIdList></Reference><Reference><Citation>Minuzzi LG, Seelaender M, Silva BSA, Cunha E, Deus MC, Vasconcellos FTF et al (2021) COVID-19 outcome relates with circulating BDNF, according to patient adiposity and age. Front Nutr 8:784429</Citation><ArticleIdList><ArticleId IdType="pubmed">34957187</ArticleId><ArticleId IdType="pmc">8704131</ArticleId><ArticleId IdType="doi">10.3389/fnut.2021.784429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong SWX, Fong SW, Young BE, Chan YH, Lee B, Amrun SN et al (2021) Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients. Open Forum Infect Dis 8(6):ofab156</Citation><ArticleIdList><ArticleId IdType="pubmed">34095336</ArticleId><ArticleId IdType="pmc">8083585</ArticleId><ArticleId IdType="doi">10.1093/ofid/ofab156</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrella C, Nenna R, Petrarca L, Tarani F, Paparella R, Mancino E et al (2022) Serum NGF and BDNF in long-COVID-19 adolescents: a pilot study. Diagnostics (Basel, Switzerland) 12(5):1162</Citation><ArticleIdList><ArticleId IdType="pubmed">35626317</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrella C, Zingaropoli MA, Ceci FM, Pasculli P, Latronico T, Liuzzi GM et al (2023) COVID-19 affects serum brain-derived neurotrophic factor and neurofilament light chain in aged men: implications for morbidity and mortality. Cells 12(4):655</Citation><ArticleIdList><ArticleId IdType="pubmed">36831321</ArticleId><ArticleId IdType="pmc">9954454</ArticleId><ArticleId IdType="doi">10.3390/cells12040655</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-de Prada L, Gorgojo-Galindo &#xd3;, Fierro I, Mart&#xed;nez-Garc&#xed;a AM, de Quintana GS, Guti&#xe9;rrez-Bustillo R et al (2022) Time evolution of cytokine profiles associated with mortality in COVID-19 hospitalized patients. Front Immunol 13:946730</Citation><ArticleIdList><ArticleId IdType="pubmed">36238287</ArticleId><ArticleId IdType="pmc">9551198</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.946730</ArticleId></ArticleIdList></Reference><Reference><Citation>Savic G, Stevanovic I, Mihajlovic D, Jurisevic M, Gajovic N, Jovanovic I et al (2022) MMP-9/BDNF ratio predicts more severe COVID-19 outcomes. Int J Med Sci 19(13):1903&#x2013;1911</Citation><ArticleIdList><ArticleId IdType="pubmed">36438922</ArticleId><ArticleId IdType="pmc">9682503</ArticleId><ArticleId IdType="doi">10.7150/ijms.75337</ArticleId></ArticleIdList></Reference><Reference><Citation>Young BE, Ong SWX, Ng LFP, Anderson DE, Chia WN, Chia PY et al (2021) Viral dynamics and immune correlates of coronavirus disease 2019 (COVID-19) severity. Clin Infect Dis 73(9):E2932&#x2013;E2942</Citation><ArticleIdList><ArticleId IdType="pubmed">32856707</ArticleId><ArticleId IdType="doi">10.1093/cid/ciaa1280</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima Giacobbo B, Doorduin J, Klein HC, Dierckx RA, Bromberg E, de Vries EF (2019) Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation. Mol Neurobiol 56:3295&#x2013;3312</Citation><ArticleIdList><ArticleId IdType="pubmed">30117106</ArticleId><ArticleId IdType="doi">10.1007/s12035-018-1283-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K (2016) Ethnic differences in the serum levels of proBDNF, a precursor of brain-derived neurotrophic factor (BDNF), in mood disorders. Eur Arch Psychiatry Clin Neurosci 266(3):285&#x2013;287</Citation><ArticleIdList><ArticleId IdType="pubmed">26338800</ArticleId><ArticleId IdType="doi">10.1007/s00406-015-0641-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K (2015) Brain-derived neurotrophic factor (BDNF) and its precursor proBDNF as diagnostic biomarkers for major depressive disorder and bipolar disorder. Eur Arch Psychiatry Clin Neurosci 265(1):83&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pubmed">25362578</ArticleId><ArticleId IdType="doi">10.1007/s00406-014-0557-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato C (2017) Releasing mechanism of neurotrophic factors via polysialic acid. Vitam Horm 104:89&#x2013;112</Citation><ArticleIdList><ArticleId IdType="pubmed">28215308</ArticleId><ArticleId IdType="doi">10.1016/bs.vh.2016.11.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Blanc J, Fleury S, Boukhatem I, B&#xe9;langer J-C, Welman M (2020) Platelets selectively regulate the release of BDNF, but not that of its precursor protein, proBDNF. Front Immunol 11:575607</Citation><ArticleIdList><ArticleId IdType="pubmed">33324399</ArticleId><ArticleId IdType="pmc">7723927</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2020.575607</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelmann E, Le&#xdf;mann V, Brigadski T (2014) Pre-and postsynaptic twists in BDNF secretion and action in synaptic plasticity. Neuropharmacology 76:610&#x2013;627</Citation><ArticleIdList><ArticleId IdType="pubmed">23791959</ArticleId><ArticleId IdType="doi">10.1016/j.neuropharm.2013.05.043</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MJF, Boulle F, Steinbusch HW, van den Hove DLA, Kenis G, Lanfumey L (2018) Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression. Psychopharmacology 235(8):2195&#x2013;2220</Citation><ArticleIdList><ArticleId IdType="pubmed">29961124</ArticleId><ArticleId IdType="pmc">6061771</ArticleId><ArticleId IdType="doi">10.1007/s00213-018-4950-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho A, Caldeira M, Santos S, Duarte C (2008) Role of the brain-derived neurotrophic factor at glutamatergic synapses. Br J Pharmacol 153(S1):S310&#x2013;S324</Citation><ArticleIdList><ArticleId IdType="pubmed">18059328</ArticleId><ArticleId IdType="doi">10.1038/sj.bjp.0707509</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinowich K, Lu B (2008) Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33(1):73&#x2013;83</Citation><ArticleIdList><ArticleId IdType="pubmed">17882234</ArticleId><ArticleId IdType="doi">10.1038/sj.npp.1301571</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M et al (2011) Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 14(3):347&#x2013;353</Citation><ArticleIdList><ArticleId IdType="pubmed">20604989</ArticleId><ArticleId IdType="doi">10.1017/S1461145710000738</ArticleId></ArticleIdList></Reference><Reference><Citation>Colucci-D&#x2019;Amato L, Speranza L, Volpicelli F (2020) Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer. Int J Mol Sci 21(20):7777</Citation><ArticleIdList><ArticleId IdType="pubmed">33096634</ArticleId><ArticleId IdType="pmc">7589016</ArticleId><ArticleId IdType="doi">10.3390/ijms21207777</ArticleId></ArticleIdList></Reference><Reference><Citation>Polacchini A, Metelli G, Francavilla R, Baj G, Florean M, Mascaretti LG et al (2015) A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays. Sci Rep 5(1):17989</Citation><ArticleIdList><ArticleId IdType="pubmed">26656852</ArticleId><ArticleId IdType="pmc">4675070</ArticleId><ArticleId IdType="doi">10.1038/srep17989</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Lin C, Fan Z, Yu W, Cao M, Ke C et al (2019) Serum cytokines and clinical features in patients with fever and thrombocytopenia syndrome. Clin Chim Acta Int J Clin Chem 494:22&#x2013;30</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2019.02.034</ArticleId></ArticleIdList></Reference><Reference><Citation>Torcia M, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, Rubartelli A et al (1996) Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85(3):345&#x2013;356</Citation><ArticleIdList><ArticleId IdType="pubmed">8616890</ArticleId><ArticleId IdType="doi">10.1016/S0092-8674(00)81113-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Boukhatem I, Fleury S, Welman M, Le Blanc J, Thys C, Freson K et al (2021) The brain-derived neurotrophic factor prompts platelet aggregation and secretion. Blood Adv 5(18):3568&#x2013;3580</Citation><ArticleIdList><ArticleId IdType="pubmed">34546355</ArticleId><ArticleId IdType="pmc">8945584</ArticleId><ArticleId IdType="doi">10.1182/bloodadvances.2020004098</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper SD (2017) Nerve growth factor: a neuroimmune crosstalk mediator for all seasons. Immunolaogy 151(1):1&#x2013;15</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12717</ArticleId></ArticleIdList></Reference><Reference><Citation>Motaghinejad M, Gholami M (2020) Possible neurological and mental outcomes of COVID-19 infection: a hypothetical role of ACE-2\Mas\BDNF signaling pathway. Int J Preventive Med 11(1):2</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijpvm.IJPVM_114_20</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorkiewicz P, Waszkiewicz N (2021) Biomarkers of post-COVID depression. J Clin Med 10(18):4142</Citation><ArticleIdList><ArticleId IdType="pubmed">34575258</ArticleId><ArticleId IdType="pmc">8470902</ArticleId><ArticleId IdType="doi">10.3390/jcm10184142</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon A, Buriani A, DalToso R, Fabris M, Romanello S, Aloe L et al (1994) Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci 91(9):3739&#x2013;3743</Citation><ArticleIdList><ArticleId IdType="pubmed">8170980</ArticleId><ArticleId IdType="pmc">43657</ArticleId><ArticleId IdType="doi">10.1073/pnas.91.9.3739</ArticleId></ArticleIdList></Reference><Reference><Citation>Demers-Mathieu V, Hines DJ, Hines RM, Lavangnananda S, Fels S, Medo E (2021) Influence of previous COVID-19 and mastitis infections on the secretion of brain-derived neurotrophic factor and nerve growth factor in human milk. Int J Mol Sci 22(8):3846</Citation><ArticleIdList><ArticleId IdType="pubmed">33917718</ArticleId><ArticleId IdType="pmc">8068104</ArticleId><ArticleId IdType="doi">10.3390/ijms22083846</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloe L, Luisa Rocco M, Omar Balzamino B, Micera A (2015) Nerve growth factor: a focus on neuroscience and therapy. Curr Neuropharmacol 13(3):294&#x2013;303</Citation><ArticleIdList><ArticleId IdType="pubmed">26411962</ArticleId><ArticleId IdType="pmc">4812798</ArticleId><ArticleId IdType="doi">10.2174/1570159X13666150403231920</ArticleId></ArticleIdList></Reference><Reference><Citation>Coen M, Allali G, Adler D, Serratrice JJJomv. Hypoxemia in COVID&#x2010;19; Comment on: &#x201c;The neuroinvasive potential of SARS&#x2010;CoV2 may play a role in the respiratory failure of COVID&#x2010;19 patients&#x201d;. 2020;92(10):1705.</Citation></Reference><Reference><Citation>Biondi M, Iannitelli A (2020) CoViD-19 and stress in the pandemic: &#x201c;sanity is not statistical.&#x201d; Riv Psichiatr 55(3):1&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">32051619</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS et al (2021) Symptoms, complications and management of long COVID: a review. J R Soc Med 114(9):428&#x2013;442</Citation><ArticleIdList><ArticleId IdType="pubmed">34265229</ArticleId><ArticleId IdType="pmc">8450986</ArticleId><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>